Recent investments completed by CCG:

	Touch Type - predictive text engine for smartphones and tablet computers; www.touchtype-online.com/
	Featurespace - online analytics for gaming and financial services; www.featurespace.co.uk
	Oval Medical Technologies Ltd. - autoinjector development; www.ovalmedical.com
	Augmentra - GPS based mapping applications for mobile devices; www.augmentra.com
	Base 4 Innovation - solid state DNA sequencing; www.base4innovation.co.uk
	Pneumacare - non invasive assessment of lung function; www.pneumacare.com
	GenDrive - grid connected inverters; www.gendrive.co.uk
	Enval - aluminium reclamation from packaging waste; www.enval.com
	Ubisense Ltd – high precision, real-time location tracking of high value assets; www.ubisense.net
	Light Blue Optics - miniature video projection systems; www.lightblueoptics.com
	Metalysis - refining of high value metals and alloys; www.metalysis.com
	Nujira - efficient power amplifier technology for wireless markets; www.nujira.com
	Cambridge Temperature Concepts Ltd - fertility prediction; www.temperatureconcepts.com
	Phico Therapeutics - modified phage based therapeutic platform; www.phicotherapeutics.co.uk

To date, our investors have made more than 40 investments in a wide range of technology sectors. Our portfolio has seen three good exits in recent years with several other strong candidates coming through to commercialisation; plus one investment now producing profitable dividends for our members and an expected AIM listing in the next few months.

Cambridge Capital Group is well integrated into the early-stage investment scene. We co-invest with the leading private and institutional technology investors, and enjoy a deal flow from a range of sources, including the members' own networks in south-east England and East Anglia.

We seek strong propositions at seed or start-up stage in high technology sectors, usually based on the physical sciences; our investors are looking for disruptive technologies with large niche or broad international markets. However, we will consider non-technology projects if they are well-differentiated with attractive markets, and come recommended from one of the members or the lead investor.